| Outcomes of observation vs stereotactic ablative radiation for oligometastatic prostate cancer: the ORIOLE phase 2 randomized clinical trial R Phillips, WY Shi, M Deek, N Radwan, SJ Lim, ES Antonarakis, SP Rowe, ... JAMA oncology 6 (5), 650-659, 2020 | 1008 | 2020 |
| Polyclonal breast cancer metastases arise from collective dissemination of keratin 14-expressing tumor cell clusters KJ Cheung, V Padmanaban, V Silvestri, K Schipper, JD Cohen, ... Proceedings of the National Academy of Sciences 113 (7), E854-E863, 2016 | 810 | 2016 |
| Five-year analysis of a multi-institutional prospective clinical trial of delayed intervention and surveillance for small renal masses: the DISSRM registry PM Pierorazio, MH Johnson, MW Ball, MA Gorin, BJ Trock, P Chang, ... European urology 68 (3), 408-415, 2015 | 417 | 2015 |
| BRCA1 mutation analysis of 41 human breast cancer cell lines reveals three new deleterious mutants F Elstrodt, A Hollestelle, JHA Nagel, M Gorin, M Wasielewski, ... Cancer research 66 (1), 41-45, 2006 | 339 | 2006 |
| A Phase 2/3 Prospective Multicenter Study of the Diagnostic Accuracy of Prostate Specific Membrane Antigen PET/CT with 18F-DCFPyL in Prostate Cancer … KJ Pienta, MA Gorin, SP Rowe, PR Carroll, F Pouliot, S Probst, ... The Journal of urology 206 (1), 52-61, 2021 | 327 | 2021 |
| Diagnostic Performance of 18F-DCFPyL-PET/CT in Men with Biochemically Recurrent Prostate Cancer: Results from the CONDOR Phase III, Multicenter Study MJ Morris, SP Rowe, MA Gorin, L Saperstein, F Pouliot, D Josephson, ... Clinical Cancer Research 27 (13), 3674-3682, 2021 | 325 | 2021 |
| Oligometastatic prostate cancer: definitions, clinical outcomes, and treatment considerations JJ Tosoian, MA Gorin, AE Ross, KJ Pienta, PT Tran, EM Schaeffer Nature Reviews Urology 14 (1), 15-25, 2017 | 294 | 2017 |
| Pearls and pitfalls in clinical interpretation of prostate-specific membrane antigen (PSMA)-targeted PET imaging S Sheikhbahaei, A Afshar-Oromieh, M Eiber, LB Solnes, MS Javadi, ... European journal of nuclear medicine and molecular imaging 44, 2117-2136, 2017 | 289 | 2017 |
| Active surveillance of grade group 1 prostate cancer: long-term outcomes from a large prospective cohort JJ Tosoian, M Mamawala, JI Epstein, P Landis, KJ Macura, ... European urology 77 (6), 675-682, 2020 | 212 | 2020 |
| PET imaging of prostate-specific membrane antigen in prostate cancer: current state of the art and future challenges SP Rowe, MA Gorin, ME Allaf, KJ Pienta, PT Tran, MG Pomper, AE Ross, ... Prostate cancer and prostatic diseases 19 (3), 223-230, 2016 | 182 | 2016 |
| Imaging of metastatic clear cell renal cell carcinoma with PSMA-targeted 18F-DCFPyL PET/CT SP Rowe, MA Gorin, HJ Hammers, M Som Javadi, H Hawasli, Z Szabo, ... Annals of nuclear medicine 29, 877-882, 2015 | 182 | 2015 |
| Protein kinase Cε: an oncogene and emerging tumor biomarker MA Gorin, Q Pan Molecular cancer 8, 1-8, 2009 | 175 | 2009 |
| 18F-labeled, PSMA-targeted radiotracers: leveraging the advantages of radiofluorination for prostate cancer molecular imaging RA Werner, T Derlin, C Lapa, S Sheikbahaei, T Higuchi, FL Giesel, S Behr, ... Theranostics 10 (1), 1, 2020 | 171 | 2020 |
| Proposal for a structured reporting system for prostate-specific membrane antigen–targeted PET imaging: PSMA-RADS version 1.0 SP Rowe, KJ Pienta, MG Pomper, MA Gorin Journal of Nuclear Medicine 59 (3), 479-485, 2018 | 168 | 2018 |
| Prospective evaluation of 99mTc-sestamibi SPECT/CT for the diagnosis of renal oncocytomas and hybrid oncocytic/chromophobe tumors MA Gorin, SP Rowe, AS Baras, LB Solnes, MW Ball, PM Pierorazio, ... European urology 69 (3), 413-416, 2016 | 168 | 2016 |
| Imaging of nonprostate cancers using PSMA-targeted radiotracers: rationale, current state of the field, and a call to arms RAS Fragomeni, T Amir, S Sheikhbahaei, SC Harvey, MS Javadi, ... Journal of Nuclear Medicine 59 (6), 871-877, 2018 | 155 | 2018 |
| Positive surgical margins in robot-assisted partial nephrectomy: a multi-institutional analysis of oncologic outcomes (leave no tumor behind) A Khalifeh, JH Kaouk, S Bhayani, C Rogers, M Stifelman, YS Tanagho, ... The Journal of urology 190 (5), 1674-1679, 2013 | 155 | 2013 |
| PSMA-RADS version 1.0: a step towards standardizing the interpretation and reporting of PSMA-targeted PET imaging studies SP Rowe, KJ Pienta, MG Pomper, MA Gorin European urology 73 (4), 485, 2017 | 142 | 2017 |
| Grade heterogeneity in small renal masses: potential implications for renal mass biopsy MW Ball, SM Bezerra, MA Gorin, M Cowan, CP Pavlovich, PM Pierorazio, ... The Journal of urology 193 (1), 36-40, 2015 | 139 | 2015 |
| Growth kinetics of small renal masses on active surveillance: variability and results from the DISSRM registry AC Uzosike, HD Patel, R Alam, ZR Schwen, M Gupta, MA Gorin, ... The Journal of urology 199 (3), 641-648, 2018 | 132 | 2018 |